acetylcysteine has been researched along with Lung Diseases in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (39.78) | 18.7374 |
1990's | 20 (21.51) | 18.2507 |
2000's | 18 (19.35) | 29.6817 |
2010's | 17 (18.28) | 24.3611 |
2020's | 1 (1.08) | 2.80 |
Authors | Studies |
---|---|
Adir, Y; Alyan, M; Arber Raviv, S; Dor, E; Egorov, E; Farkash, S; Flikshtain, OD; Gal, Y; Harush, MY; Kaneti, G; Korach-Rechtman, H; Koren, L; Mekies, LN; Nudelman, I; Pieters, C; Saadya, A; Schroeder, A; Shainsky, J; Shklover, J; Zano, A | 1 |
Abid, S; Adnot, S; Attwe, A; Beaulieu, D; Bernard, D; Born, E; Bourachot, B; Breau, M; Collin, G; Czibik, G; Flaman, JM; Houssaini, A; Lipskaia, L; Marcos, E; Mechta-Grigoriou, F; Palazzo, A; Tran Van Nhieu, J | 1 |
Button, BM; Holland, AE; Le Maitre, C; Romero, L; Steward, R; Tarrant, BJ; Thompson, BR | 1 |
Devereaux, A; Liang, NC | 1 |
Ghanei, M; Hashjin, MM; Panahi, Y; Rezaee, R; Sahebkar, A | 1 |
Chen, C; Hei, Z; Li, X; Liu, D; Wei, X; Yao, W; Zhang, Z | 1 |
Fairhall, S; Jenner, J; Jugg, B; Mann, T; Perrott, R; Rutter, S; Salguero, J; Sciuto, AM; Shute, J; Smith, A | 1 |
Nash, EF; Ratjen, F; Stephenson, A; Tam, J; Tullis, E | 1 |
Akca, B; Battaloglu, B; Colak, MC; Disli, OM; Erdil, F; Erdil, N; Eroglu, T; Yetkin, O | 1 |
Güler, G; Ozgur, E; Seyhan, N; Türközer, Z | 1 |
Nash, EF; Ratjen, F; Stephenson, A; Tullis, E | 1 |
Carlson, GP; Mahlapuu, R; Meszka-Jordan, A; Soomets, U | 1 |
Breysse, PN; Chiang, ET; Chillrud, SN; Garcia, JG; Geyh, AS; Lang, GD; Moreno-Vinasco, L; Natarajan, V; Pendyala, S; Samet, JM; Wang, T | 1 |
Celik, Y; Cigdem, MK; Kizil, G; Kizil, M; Nergiz, Y; Onen, A | 1 |
Baas, P; Beijnen, JH; Keizer, RJ | 1 |
Bracher, A; Doran, SF; Leustik, M; Matalon, S; Postlethwait, EM; Squadrito, GL; Yadav, AK | 1 |
Day, BJ; Gould, NS | 1 |
Johnson, DC | 1 |
Gillissen, A | 1 |
Chu, HW; Kosmider, B; Mason, RJ; Messier, EM | 1 |
Guo, XC; Jiang, JF; Liu, HQ; Shen, C; Wang, Q; Wu, MJ; Xu, ZY; Zhou, WG; Zhu, H | 1 |
Avlan, D; Cinel, I; Cinel, L; Dikmengil, M; Koksel, O; Okcu, H; Oral, U; Ozdulger, A; Unlu, A | 1 |
Chatterjee, D; Das, SK; Mukherjee, S; Smith, MG | 1 |
SUDDARTH, SB | 1 |
REAS, HW | 2 |
JACOBS, LW; MEDLER, EM; SARETT, HP; SHEFFNER, AL | 1 |
WEBB, WR | 1 |
DEGERLI, IU; WEBB, WR | 1 |
Li, HZ; Li, SQ; Qi, HW; Wu, CG; Zhang, J | 1 |
Boulanger, P; Guerin, JC; Lebas, FX; Leophonte, P; Liard, F; Terrioux, P | 1 |
Aitio, ML | 1 |
Hosogi, S; Iwasaki, Y; Kono, K; Kuwahara, H; Marunaka, Y; Nagata, K; Ohsugi, S; Yamada, T; Yuba, T | 1 |
Chen, HI; Chuang, IC; Kao, SJ; Liu, DD | 1 |
Doctor, BP; Gordon, RK; Katos, AM; Moran, TS; Nambiar, MP; Rezk, PE; Sciuto, AM; Steele, KE; Wajda, NA | 1 |
Cooke, MS; Grigg, J; Panickar, JR | 1 |
Hofer, CK; Metzger, U; Seifert, B; Zingg, U; Zollinger, A | 1 |
Boogaard, R; de Jongste, JC; Merkus, PJ | 1 |
Dal Pizzol, F; Pinho, RA; Rocha, LG; Silva, LA; Silveira, PC; Soares, FS; Streck, EL; Teixeira, KC; Valença, SS | 1 |
Bartos, V; Brozmanova, M; Javorka, M; Masar, J; Plank, L; Plevkova, J; Tatar, M | 1 |
Hsia, DY; O'Flynn, M; Rowley, WF | 1 |
Ovchinnikov, AA; Rabicheva, MI; Vaĭsberg, LA | 1 |
Balestra, L; Henriquet, F; Mereto, GC | 1 |
Barbero, EA; Lucas, MC; Ludeña, MD; Sánchez-Gascón, F | 1 |
Brien, JF; Leeder, RG; Massey, TE | 1 |
Bernard, GR; Morris, PE | 1 |
Avidor, I; Benjaminov, O; Hoffer, E; Merzbach, D; Shenker, L; Tabak, A; Taitelman, U; Tamir, A | 1 |
Kelly, FJ; Langley, SC | 1 |
Maier, KL | 1 |
Blackwell, TR; Blackwell, TS; Christman, BW; Christman, JW; Holden, EP | 1 |
Baum, Y; Hoffer, E; Shenker, L; Tabak, A | 1 |
Buhl, R; Meyer, A; Vogelmeier, C | 1 |
Ishii, Y; Kitamura, S; Yamasawa, H | 1 |
Brand, PL; Duijvestijn, YC; Gerritsen, J | 1 |
Meyboom-de Jong, B | 1 |
Davreux, CJ; McGilvray, ID; Nathens, AB; Rotstein, OD; Shek, PN; Soric, I; Suntres, ZE; Watson, RW | 1 |
Dekhuijzen, PN | 1 |
Gillissen, A; Nowak, D | 1 |
Domenighetti, G; Quattropani, C; Schaller, MD | 1 |
Ben-Abraham, R; Karchevski, E; Rudick, V; Weinbroum, AA | 1 |
Anderson, DR; Byers, SL; Vesely, KR | 1 |
Boehm, G; Theile, H | 1 |
Tarentini Trojani, F | 1 |
Belik, J; Bibi, H; Oullette, M; Seifert, B | 1 |
Bernard, GR | 1 |
de Leval, M; Fradet, G; Helms, P; Higenbottam, TW; Scott, JP; Sharples, L; Smyth, RL; Wallwork, J; Whitehead, B | 1 |
Jamieson, DD; Kerr, DR; Unsworth, I | 1 |
Bebout, DE; Glennow, C; Gray, AT; Mathieu-Costello, O; Natterson, PD; Wagner, PD | 1 |
Bernard, GR; Brigham, KL; English, DK; Lucht, WD; Serafin, WE | 1 |
Butler, JA; Byrne, FD; Patterson, CE; Rhodes, ML | 1 |
Balynia, NA; Ginters, JJ; Magalif, NI; Marga, OIa; Utkin, VV | 1 |
Chiummariello, A; De Luca, L | 1 |
Stadeler, HJ | 1 |
Hunter, AR | 1 |
Brooks, RC; Rao, S; Sproule, BJ; Wilson, DB | 1 |
Ahlgren, EW | 1 |
Günthner, W | 1 |
Borgia, M; Porsio, A | 1 |
Alberto, S; Brusasco, L; Colongo, PG; Frigerio, G | 1 |
Kulkarni, TP | 1 |
Stephan, U | 1 |
Ciocatto, E; Marchiaro, G; Trompeo, MA | 1 |
Fossati, C | 1 |
Hirsch, SR; Kory, RC; Zastrow, JE | 1 |
Lande, M | 1 |
Carnimeo, N; Iaia, E | 1 |
Sheffner, AL | 1 |
Ramirez, J | 1 |
17 review(s) available for acetylcysteine and Lung Diseases
Article | Year |
---|---|
Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Topics: Acetylcysteine; Administration, Inhalation; Bronchiectasis; Chronic Disease; Deoxyribonuclease I; Expectorants; Forced Expiratory Volume; Humans; Lung Diseases; Mannitol; Mesna; Mucociliary Clearance; Quality of Life; Recombinant Proteins; Saline Solution, Hypertonic; Symptom Flare Up; Vital Capacity | 2017 |
Potential Utility of N-acetylcysteine for Treating Mustard Lung.
Topics: Acetylcysteine; Apoptosis; Chemical Warfare Agents; Humans; Inflammation; Lung; Lung Diseases; Mustard Gas; Oxidative Stress | 2017 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fibrosis; Expectorants; Glutathione; Humans; Lung Diseases; Mucociliary Clearance; Nebulizers and Vaporizers; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic | 2013 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fibrosis; Expectorants; Humans; Lung Diseases; Mucociliary Clearance; Randomized Controlled Trials as Topic | 2009 |
Mechanisms and modification of chlorine-induced lung injury in animals.
Topics: Acetylcysteine; Animals; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Chlorine; Gases; Inhalation Exposure; Lung; Lung Diseases; Models, Animal; Rabbits; Rats | 2010 |
[Oxidative stress in bronchopulmonary disease: contribution of N-acetylcysteine (NAC)].
Topics: Acetylcysteine; Glutathione; Humans; Inflammation; Lung Diseases; Oxidative Stress | 2005 |
N-acetylcysteine -- passe-partout or much ado about nothing?
Topics: Acetylcysteine; Anti-HIV Agents; Antioxidants; Cardiovascular Diseases; Drug Therapy, Combination; Expectorants; HIV Infections; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Neoplasms; Oxidative Stress; Reactive Oxygen Species | 2006 |
Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Topics: Acetylcysteine; Adolescent; Child; Child, Preschool; Deoxyribonuclease I; Expectorants; Humans; Infant; Lung Diseases; Mucociliary Clearance; Physical Therapy Modalities; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic | 2007 |
Significance of glutathione in lung disease and implications for therapy.
Topics: Acetylcysteine; Animals; Cysteine; Disease Models, Animal; Glutathione; Humans; Inflammation; Lung Diseases; NF-kappa B | 1994 |
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy.
Topics: Acetylcysteine; Aerosols; Antioxidants; Glutathione; HIV Infections; Humans; Lung; Lung Diseases; Protease Inhibitors; Pulmonary Fibrosis | 1996 |
[Acetylcysteine in children with lung disorders prescribed by one-third of family physicians: no support in the literature].
Topics: Acetylcysteine; Child; Child, Preschool; Drug Prescriptions; Expectorants; Family Practice; Humans; Lung Diseases | 1997 |
Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Topics: Acetylcysteine; Ambroxol; Animals; Expectorants; Free Radical Scavengers; Humans; Lung; Lung Diseases | 1998 |
[Therapeutic use of N-acetylcysteine in acute lung diseases].
Topics: Acetylcysteine; Acute Disease; Free Radical Scavengers; Humans; Lung Diseases; Reactive Oxygen Species | 1999 |
N-acetylcysteine in experimental and clinical acute lung injury.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Endotoxins; Free Radical Scavengers; Glutathione; Granulocytes; Humans; Lung Diseases; Models, Biological; Respiratory Distress Syndrome | 1991 |
[Role of free radicals in respiratory pathology or the battle for an electron].
Topics: Acetylcysteine; Emphysema; Free Radicals; Humans; Hydrogen Peroxide; Lung Diseases; Oxygen Consumption; Respiratory Tract Infections; Superoxides | 1987 |
[Mucoviscidosis (review of the literature)].
Topics: Acetylcysteine; Adult; Aerosols; Anti-Bacterial Agents; Bronchi; Bronchial Diseases; Bronchopneumonia; Cough; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Lung Compliance; Lung Diseases; Middle Aged; Pancreas; Radiography; Sweating | 1968 |
[Inhalation therapy from the modern point of view].
Topics: Acetylcysteine; Aerosols; Aniline Compounds; Bronchodilator Agents; Chronic Disease; Dexamethasone; Expectorants; Humans; Lung Diseases; Respiratory Function Tests; Respiratory Therapy; Respiratory Tract Diseases; Toluene | 1971 |
6 trial(s) available for acetylcysteine and Lung Diseases
Article | Year |
---|---|
Topics: Acetylcysteine; Administration, Inhalation; Breath Tests; Exhalation; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Liver Transplantation; Lung; Lung Diseases; Male; Middle Aged; Oxidative Stress; Postoperative Complications; Tumor Necrosis Factor-alpha; Uteroglobin | 2018 |
The effects of N-acetylcysteine on pulmonary functions in patients undergoing on-pump coronary artery surgery: a double blind placebo controlled study.
Topics: Acetylcysteine; Aged; Blood Gas Analysis; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lung Diseases; Male; Middle Aged; Prospective Studies; Respiratory Function Tests | 2016 |
[Oral mucosolvin therapy of pulmonary symptoms of mucoviscidosis].
Topics: Acetylcysteine; Administration, Oral; Clinical Trials as Topic; Cystic Fibrosis; Humans; Infant; Lung Diseases | 1979 |
Intratracheal N-acetylcysteine use in infants with chronic lung disease.
Topics: Acetylcysteine; Airway Resistance; Chronic Disease; Humans; Infant; Infant, Newborn; Infant, Premature; Instillation, Drug; Intubation, Intratracheal; Lung Compliance; Lung Diseases; Lung Volume Measurements; Prospective Studies; Pulmonary Gas Exchange; Respiration, Artificial | 1992 |
N-acetylcysteine in experimental and clinical acute lung injury.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Endotoxins; Free Radical Scavengers; Glutathione; Granulocytes; Humans; Lung Diseases; Models, Biological; Respiratory Distress Syndrome | 1991 |
[Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies].
Topics: Acetylcysteine; Adult; Aged; Anti-Bacterial Agents; Asthma; Bronchial Diseases; Bronchiectasis; Bronchitis; Chronic Disease; Female; Humans; Lung Abscess; Lung Diseases; Male; Middle Aged; Pulmonary Emphysema; Respiration; Respiratory Insufficiency | 1968 |
71 other study(ies) available for acetylcysteine and Lung Diseases
Article | Year |
---|---|
Lung targeted liposomes for treating ARDS.
Topics: Acetylcysteine; Animals; COVID-19; Humans; Inflammation; Lipopolysaccharides; Liposomes; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Nanoparticles; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 2022 |
The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice.
Topics: Acetylcysteine; Adenocarcinoma of Lung; Animals; Antioxidants; Disease Models, Animal; Female; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mice; Mice, Knockout; Oxidative Stress; Proto-Oncogene Proteins c-jun; Pulmonary Emphysema; Reactive Oxygen Species | 2019 |
Integrative Medicine (Complementary and Alternative Medicine) for the Lungs.
Topics: Acetylcysteine; Acupressure; Acupuncture Therapy; Antioxidants; Breathing Exercises; Complementary Therapies; Dietary Supplements; Humans; Integrative Medicine; Lung Diseases; Meditation; Mind-Body Therapies; Mindfulness; Probiotics; Transcutaneous Electric Nerve Stimulation; Vitamin D; Vitamins; Yoga | 2017 |
N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine.
Topics: Acetylcysteine; Administration, Inhalation; Aerosols; Animals; Antidotes; Antioxidants; Bronchoalveolar Lavage Fluid; Chemical Warfare Agents; Disease Models, Animal; Expectorants; Female; Gas Poisoning; Lung; Lung Diseases; Mustard Gas; Neutrophil Infiltration; Random Allocation; Respiratory Insufficiency; Survival Analysis; Sus scrofa | 2013 |
Antioxidants alleviate electric field-induced effects on lung tissue based on assays of heme oxygenase-1, protein carbonyl content, malondialdehyde, nitric oxide, and hydroxyproline.
Topics: Acetylcysteine; Animals; Antioxidants; Biodiversity; Catechin; Electromagnetic Fields; Guinea Pigs; Heme Oxygenase-1; Hydroxyproline; Lung Diseases; Male; Malondialdehyde; Nitric Oxide; Protein Carbonylation; Random Allocation | 2009 |
Oxidative stress due to (R)-styrene oxide exposure and the role of antioxidants in non-Swiss albino (NSA) mice.
Topics: Acetylcysteine; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Cell Count; Chemical and Drug Induced Liver Injury; Epoxy Compounds; Glutathione; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Lung Diseases; Male; Mice; Oxidative Stress; Quinolines; Reactive Oxygen Species; Stereoisomerism; Trans-Activators | 2009 |
Particulate matter disrupts human lung endothelial barrier integrity via ROS- and p38 MAPK-dependent pathways.
Topics: Acetylcysteine; Air Pollutants; Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Lung; Lung Diseases; Molecular Chaperones; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Particulate Matter; Phosphorylation; Pyridines; Reactive Oxygen Species | 2010 |
Is there a role for antioxidants in prevention of pulmonary hypoplasia in nitrofen-induced rat model of congenital diaphragmatic hernia?
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Disease Models, Animal; Drug Synergism; Female; Fetus; Free Radical Scavengers; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Lipid Peroxidation; Lung; Lung Diseases; Male; Maternal-Fetal Exchange; Pesticides; Phenyl Ethers; Pregnancy; Proteins; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Vitamin E | 2010 |
'Flooding' of the lungs and severe dyspnea in a patient with bronchoalveolar carcinoma.
Topics: Acetylcysteine; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Inhalation; Administration, Oral; Dyspnea; Expectorants; Female; Humans; Hyperhomocysteinemia; Lung; Lung Diseases; Lung Neoplasms; Middle Aged; Nebulizers and Vaporizers; Risk Factors; Severity of Illness Index; Sputum | 2011 |
Targeting maladaptive glutathione responses in lung disease.
Topics: Acetylcysteine; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Glutathione; Humans; Lung; Lung Diseases; Oxidation-Reduction | 2011 |
Airway mucus function and dysfunction.
Topics: Acetylcysteine; Humans; Insufflation; Lung Diseases; Mucus; Respiratory Physiological Phenomena; Tracheostomy | 2011 |
[Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Arthritis; Bronchitis; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Expectorants; Free Radical Scavengers; Humans; Lung Diseases; Lung Diseases, Interstitial; Pulmonary Disease, Chronic Obstructive | 2011 |
Human alveolar epithelial cell injury induced by cigarette smoke.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Apoptosis; Benzimidazoles; Chromans; Epithelial Cells; Humans; In Situ Nick-End Labeling; Lung Diseases; Microscopy, Fluorescence; Necrosis; NF-E2-Related Factor 2; Oxidative Stress; Phenotype; Propidium; Pulmonary Alveoli; Smoking | 2011 |
N-acetylcysteine-pretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Cell Survival; Embryonic Stem Cells; Humans; Lung Diseases; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Nude; Reactive Oxygen Species | 2013 |
The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model.
Topics: Acetylcysteine; Animals; Apoptosis; Cecum; Disease Models, Animal; Intestinal Perforation; Ligation; Lipid Peroxidation; Lung; Lung Diseases; Male; Malondialdehyde; Nitrates; Nitrites; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Resuscitation; Systemic Inflammatory Response Syndrome | 2003 |
Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue.
Topics: Acetylcysteine; Animals; Caspases; Ceramides; Electrophoretic Mobility Shift Assay; Free Radical Scavengers; Free Radicals; Guinea Pigs; Lung; Lung Diseases; Male; Mustard Gas; NF-kappa B; Sphingomyelin Phosphodiesterase; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2003 |
Acetylcysteine, a new and effective mucolytic agent.
Topics: Acetylcysteine; Bronchi; Cysteine; Cystic Fibrosis; Expectorants; Humans; Lung Diseases | 1963 |
THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.
Topics: Acetylcysteine; Adolescent; Child; Cysteine; Cystic Fibrosis; Expectorants; Humans; Lung Diseases; Respiration; Respiratory Therapy | 1963 |
THE IN VITRO REDUCTION IN VISCOSITY OF HUMAN TRACHEOBRONCHIAL SECRETIONS BY ACETYLCYSTEINE.
Topics: Acetates; Acetylcysteine; Bronchitis; Chemistry Techniques, Analytical; Cysteine; Expectorants; Humans; In Vitro Techniques; Lung Diseases; Pharmacology; Pulmonary Emphysema; Ribonucleases; Sputum; Viscosity | 1964 |
NEW MUCOLYTIC AGENTS FOR SPUTUM LIQUEFACTION.
Topics: Acetylcysteine; Asthma; Bronchial Diseases; Cysteine; Cystic Fibrosis; Expectorants; Fibrin; Humans; Lung Diseases; Mucus; Sputum; Toxicology | 1964 |
THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.
Topics: Acetylcysteine; Adolescent; Child; Cysteine; Cystic Fibrosis; Humans; Infant; Klebsiella; Lung Diseases; Pneumonia; Proteus Infections; Pseudomonas Infections; Pulmonary Emphysema; Radiography, Thoracic; Respiratory Function Tests; Respiratory Therapy; Spirometry; Staphylococcal Infections | 1964 |
[EFFECTIVENESS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE, IN POSTOPERATIVE PULMONARY COMPLICATIONS].
Topics: Acetylcysteine; Drug Therapy; Expectorants; Humans; Lung Diseases; Postoperative Complications; Postoperative Period | 1965 |
[NF-kappaB expression in lung tissue of acute lung injury rat model and the influence by antioxidant N-acetylcysteine].
Topics: Acetylcysteine; Animals; Epithelial Cells; Lipopolysaccharides; Lung; Lung Diseases; Male; NF-kappa B; Rats; Rats, Sprague-Dawley | 2004 |
Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury.
Topics: Acetylcysteine; Administration, Inhalation; Aerosols; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Cell Count; Free Radical Scavengers; Glutathione; Hyperoxia; Lipid Peroxidation; Lung; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase | 2007 |
N-acetylcysteine attenuates the acute lung injury caused by phorbol myristate acetate in isolated rat lungs.
Topics: Acetylcysteine; Acute Disease; Animals; Blood Pressure; Body Weight; Bronchoalveolar Lavage Fluid; Capillary Permeability; Expectorants; Free Radical Scavengers; In Vitro Techniques; Inflammation Mediators; Lung; Lung Diseases; Male; Nitric Oxide; Organ Size; Pulmonary Artery; Pulmonary Edema; Random Allocation; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2007 |
Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.
Topics: Acetylcysteine; Acute Disease; Animals; Atropine Derivatives; Body Weight; Bronchoalveolar Lavage Fluid; Chemical Warfare Agents; Guinea Pigs; Inhalation Exposure; Lung Diseases; Male; Organ Size; Organothiophosphorus Compounds; Proteins; Pulmonary Surfactants; Respiratory Mucosa | 2007 |
Case 3-2007: a boy with respiratory insufficiency.
Topics: Acetylcysteine; Child; Female; Free Radical Scavengers; Glutathione; Hemosiderosis; Humans; Lung Diseases; Male; Oxidative Stress; Respiratory Insufficiency | 2007 |
High dose N-acetylcysteine to prevent pulmonary complications in partial or total transthoracic esophagectomy: results of a prospective observational study.
Topics: Acetylcysteine; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Length of Stay; Lung Diseases; Male; Middle Aged; Oxygen; Postoperative Period; Prospective Studies; Retrospective Studies; Treatment Outcome | 2007 |
Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Bleomycin; Catalase; Deferoxamine; Drug Therapy, Combination; Fibrosis; Iron Chelating Agents; L-Lactate Dehydrogenase; Lipid Peroxidation; Lung; Lung Diseases; Male; Mice; Mice, Inbred Strains; Oxidative Stress; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Citric Acid; Cough; Disease Models, Animal; Guinea Pigs; Hyperoxia; Lung; Lung Diseases; Male; Oxidative Stress; Physical Stimulation; Reflex | 2007 |
Cystic fibrosis of the pancreas.
Topics: Acetylcysteine; Anti-Bacterial Agents; Bronchi; Bronchial Diseases; Child; Cystic Fibrosis; Digestive System; Drainage; Fecal Impaction; Humans; Hyperglycemia; Intestinal Obstruction; Liver Cirrhosis; Lung; Lung Diseases; Meconium; Mucus; Pneumatosis Cystoides Intestinalis; Respiratory Function Tests; Respiratory Insufficiency; Respiratory Therapy; Respiratory Tract Diseases; Salivary Glands; Sweat | 1966 |
[Comparative effectiveness of various methods of bronchoscopic sanation in chronic nonspecific lung diseases].
Topics: Acetylcysteine; Adolescent; Adult; Aged; Bronchoscopy; Evaluation Studies as Topic; Expectorants; Furagin; Humans; Lung Diseases; Mesna; Middle Aged; Sodium Chloride; Therapeutic Irrigation | 1980 |
Alveolar surfactant in lungs of operated patients after acetylcysteine treatment.
Topics: Acetylcysteine; Humans; Lung Diseases; Pulmonary Alveoli; Pulmonary Surfactants | 1980 |
Effects of N-acetylcysteine on hyperoxic lung in the rat.
Topics: Acetylcysteine; Animals; Hyperoxia; Lung Diseases; Rats; Rats, Wistar | 1995 |
Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster.
Topics: Acetylcysteine; Allyl Compounds; Amiodarone; Animals; Antioxidants; Butylated Hydroxyanisole; Cricetinae; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Lung; Lung Diseases; Male; Mesocricetus; Oxidative Stress; Pulmonary Fibrosis; Sulfides; Superoxide Dismutase | 1994 |
N-acetylcysteine delays the infiltration of inflammatory cells into the lungs of paraquat-intoxicated rats.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Chemotactic Factors; Chemotaxis, Leukocyte; Inflammation; Liver; Lung Diseases; Male; Neutrophils; Paraquat; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Superoxides | 1993 |
N-acetylcysteine ameliorates hyperoxic lung injury in the preterm guinea pig.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Catalase; Disease Models, Animal; Female; Glutathione; Glutathione Peroxidase; Guinea Pigs; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung; Lung Diseases; Oxygen; Proteins; Ventilators, Mechanical | 1993 |
How the lung deals with oxidants.
Topics: Acetylcysteine; Alveolitis, Extrinsic Allergic; Animals; Free Radical Scavengers; Humans; Lung; Lung Diseases; Nitrogen Dioxide; Ozone; Reactive Oxygen Species; Respiratory Burst; Smoking | 1993 |
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Base Sequence; Chemokines, CXC; Chemotactic Factors; Chemotaxis, Leukocyte; Dinoprost; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxins; F2-Isoprostanes; Gene Expression Regulation; Glutathione; Growth Substances; Inflammation; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Lung; Lung Diseases; Male; Molecular Sequence Data; Neutrophils; NF-kappa B; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; RNA, Messenger; Sepsis | 1996 |
Paraquat-induced formation of leukotriene B4 in rat lungs: modulation by N-acetylcysteine.
Topics: Acetylcysteine; Animals; Arachidonic Acid; Bronchoalveolar Lavage Fluid; Female; Leukotriene B4; Lung; Lung Diseases; Macrophages, Alveolar; Neutrophils; Paraquat; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley | 1997 |
[Role of oxidants in adhesion molecule expression and cytokine production].
Topics: Acetylcysteine; Animals; Antioxidants; Bronchi; Cells, Cultured; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Lung Diseases; Rats; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1996 |
[Acetylcysteine prescribed by one third of family physicians for lung diseases in children; no proof in the literature].
Topics: Acetylcysteine; Child; Drug Prescriptions; Expectorants; Family Practice; Humans; Lung Diseases; Practice Patterns, Physicians' | 1997 |
N-acetyl cysteine attenuates acute lung injury in the rat.
Topics: Acetylcysteine; Acute Disease; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Capillary Permeability; CD11 Antigens; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxins; Glutathione; Hemorrhage; Lipid Peroxidation; Lipopolysaccharides; Liver; Lung; Lung Diseases; Lung Injury; Male; Neutrophil Activation; Neutrophils; Peroxidase; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1997 |
[Acetylcysteine in children with lung disorders prescribed by one third of family physicians; no support in the literature].
Topics: Acetylcysteine; Child; Expectorants; Humans; Lung Diseases | 1997 |
N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study.
Topics: Acetylcysteine; Animals; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutathione; Ischemia; Liver; Liver Circulation; Lung; Lung Diseases; Male; Perfusion; Pulmonary Circulation; Rats; Rats, Wistar; Reperfusion Injury; Respiration; Xanthine Oxidase | 2000 |
Treatment of sulfur mustard (HD)-induced lung injury.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage; Dermatologic Agents; Free Radical Scavengers; gamma-Glutamyltransferase; Lung; Lung Diseases; Male; Mustard Gas; Neutrophils; Niacinamide; Rats | 2000 |
[Pulmonary aging. Meeting at the Istituto Superiore di Sanità in Rome].
Topics: Acetylcysteine; Adult; Aging; Bronchitis; Chronic Disease; Clinical Trials as Topic; Humans; Lung; Lung Diseases; Multicenter Studies as Topic; Smoking | 1992 |
The use of heart-lung transplantation in management of terminal respiratory complications of cystic fibrosis.
Topics: Acetylcysteine; Adult; Constipation; Cystic Fibrosis; Follow-Up Studies; Heart-Lung Transplantation; Humans; Lung Diseases; Prognosis | 1990 |
Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice.
Topics: Acetylcysteine; Animals; Bleomycin; Hyperbaric Oxygenation; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Oxygen | 1987 |
Protection against pulmonary O2 toxicity by N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Dogs; Free Radicals; Glutathione; Lung Diseases; Oxygen; Respiratory Distress Syndrome; Respiratory Function Tests | 1989 |
Prevention of release of granulocyte aggregants into sheep lung lymph following endotoxemia by N-acetylcysteine.
Topics: Acetylcysteine; Animals; Cell Adhesion; Cell Aggregation; Endotoxins; Granulocytes; Leukotriene B4; Lung Diseases; Lymph; Neutrophils; Sheep | 1987 |
Tobacco smoke: respiratory tract defense mechanisms and therapeutic implications. An international symposium held in Lugano, CH, April 13-14, 1984.
Topics: Acetylcysteine; Humans; Lung; Lung Diseases; Smoke; Smoking | 1985 |
Oxidant lung injury: intervention with sulfhydryl reagents.
Topics: Acetylcysteine; Animals; Cysteamine; Humans; Lung Diseases; Mice; Oxygen; Paraquat; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1985 |
[Evaluation of the use of N-acetylcysteine in chronic suppurative diseases of the lungs].
Topics: Acetylcysteine; Adolescent; Bronchial Diseases; Bronchoscopy; Chronic Disease; Humans; Lung Diseases; Male; Middle Aged; Respiratory Therapy; Suppuration; Therapeutic Irrigation | 1972 |
Treatment by artificial ventilation of the lungs.
Topics: Acetylcysteine; Asthma; Barbiturates; Glutethimide; Humans; Humidity; Infections; Intensive Care Units; Intubation, Intratracheal; Lung Diseases; Myasthenia Gravis; Neurologic Manifestations; Nursing Care; Parenteral Nutrition; Perfusion; Porphyrias; Pulmonary Emphysema; Respiration, Artificial; Seizures; Thoracic Injuries; Tracheal Stenosis; Tracheotomy | 1967 |
Acute effects of nebulization of N-acetylcysteine on pulmonary mechanics and gas exchange.
Topics: Acetylcysteine; Aerosols; Blood Gas Analysis; Bronchial Spasm; Female; Humans; Hypercapnia; Hypoxia; Lung Compliance; Lung Diseases; Male; Respiration; Spirometry; Ventilation-Perfusion Ratio | 1970 |
Acetylcysteine--Respaire and Mucomyst.
Topics: Acetylcysteine; Cystic Fibrosis; Humans; Lung Diseases | 1970 |
Aerosol drug therapy.
Topics: Acetylcysteine; Aerosols; Anti-Bacterial Agents; Catecholamines; Deoxyribonucleases; Dexamethasone; Humans; Lung Diseases; Pharmaceutical Vehicles; Surface-Active Agents; Theophylline | 1970 |
[Inhalation therapy using secretolytics].
Topics: Acetylcysteine; Airway Resistance; Ammonium Chloride; Blood Gas Analysis; Detergents; Health Resorts; Humans; Lung Diseases; Lung Diseases, Obstructive; Oils, Volatile; Plethysmography, Whole Body; Respiratory Function Tests; Respiratory Therapy; Time Factors | 1971 |
[General use of N-acetyl-L-cysteine: controled evaluation of the mucolytic activity and tolerability].
Topics: Acetylcysteine; Adult; Female; Humans; Lung Diseases; Male; Middle Aged; Respiratory Insufficiency | 1967 |
Clinical experience with acetylcysteine--a mucolytic agent.
Topics: Acetylcysteine; Bronchiectasis; Humans; Lung Abscess; Lung Diseases; Postoperative Complications | 1968 |
[Mucoviscidosis].
Topics: Acetylcysteine; Aerosols; Anti-Bacterial Agents; Child; Cystic Fibrosis; Drainage; Humans; Lung Diseases; Pancreatic Extracts; Radiography; Ultrasonic Therapy | 1968 |
[Preliminary experience with parenteral N-acetyl-L-cysteine in resuscitation].
Topics: Acetylcysteine; Adult; Aged; Coma; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Lung Diseases; Male; Middle Aged; Pneumothorax; Poisoning; Respiratory Insufficiency; Resuscitation | 1968 |
[A new mucolytic alone or associated with an antibiotic in the treatment of bronchial-pleural-pulmonary diseases].
Topics: Acetates; Acetylcysteine; Aerosols; Bronchial Diseases; Drug Synergism; Empyema; Humans; Lung Diseases; Pleural Diseases | 1968 |
Sputum liquefying agents: a comparative in vitro evaluation.
Topics: Acetylcysteine; Bicarbonates; Humans; Lung Diseases; Mercaptoethanol; Methods; Potassium Iodide; Sodium Chloride; Sputum; Sulfhydryl Compounds; Sulfonic Acids; Urea; Viscosity | 1969 |
[A mucolytic agent: actylcysteine in the prevention and treatment of postoperative pulmonary complications].
Topics: Acetylcysteine; Humans; Lung Diseases; Postoperative Complications | 1965 |
[Experiences on aerosol treatment of bronchopulmonary diseases with tetracycline-1-methylene-lysine combined with acetylcysteine].
Topics: Acetylcysteine; Adolescent; Adult; Aged; Bronchial Diseases; Female; Heart Diseases; Humans; Lung Diseases; Lymecycline; Male; Middle Aged; Tetracycline | 1965 |
Pharmacologic agents.
Topics: Acetylcysteine; Acidosis, Respiratory; Anticoagulants; Bicarbonates; Bronchodilator Agents; Chymotrypsin; Ephedrine; Expectorants; Glucocorticoids; Guaiacol; Humans; Iodine Isotopes; Isoproterenol; Lung Diseases; Lung Diseases, Obstructive; Potassium Iodide; Sodium; Thyroid Gland; Tromethamine; Trypsin | 1965 |
Airbron.
Topics: Acetylcysteine; Aerosols; Bronchial Diseases; Humans; Lung Diseases | 1966 |
The mucolytic action of acetylcysteine.
Topics: Acetylcysteine; Humans; In Vitro Techniques; Lung Diseases; Sputum | 1966 |
Bronchopulmonary lavage. New techniques and observations.
Topics: Acetylcysteine; Amyloidosis; Asthma; Bronchitis; Bronchospirometry; Heparin; Humans; Intubation, Intratracheal; Lung Diseases; Pulmonary Alveolar Proteinosis; Solutions; Therapeutic Irrigation | 1966 |